- Home
- CTW vs RPTX Comparison
CTW vs RPTX Comparison
Compare CTW & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTW | RPTX |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | Japan | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.1M | 92.4M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CTW | RPTX |
|---|---|---|
| Price | $1.53 | $2.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 54.2K | ★ 1.0M |
| Earning Date | 11-17-2025 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $90,370,793.00 | $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,122.22 |
| P/E Ratio | $24.76 | ★ N/A |
| Revenue Growth | ★ 32.07 | N/A |
| 52 Week Low | $1.56 | $0.89 |
| 52 Week High | $4.88 | $2.66 |
Technical Indicators
Market Signals| Indicator | CTW | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 30.89 | 73.10 |
| Support Level | $1.71 | $2.50 |
| Resistance Level | $1.82 | $2.61 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 5.77 | 100.00 |
Price Performance
Historical ComparisonAbout CTW CTW Cayman Class A Ordinary Shares
CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.